Skip to main content

Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13th, at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Biljana Naumovic, Worldwide Vice President, Oncology, and Peter Lebowitz, Global Therapeutic Head, Oncology, will represent the Company in a session scheduled at 4:20 p.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48-hrs after the live webcast.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.16
-0.38 (-0.17%)
AAPL  273.30
-0.81 (-0.30%)
AMD  208.03
+0.45 (0.22%)
BAC  54.98
-0.35 (-0.63%)
GOOG  306.21
-3.11 (-1.01%)
META  654.18
+6.67 (1.03%)
MSFT  474.99
+0.17 (0.04%)
NVDA  176.65
+0.36 (0.20%)
ORCL  188.94
+4.03 (2.18%)
TSLA  478.43
+3.12 (0.66%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.